
According to a report from Watoday on November 9, despite an estimated one million Australians using e-cigarettes, in a plan implemented by the federal government to include e-cigarettes as pharmacy products to combat the black market, only 3,500 sales were made in the first month.
Australia has approximately 5800 pharmacies nationwide, but data shows that thousands of them do not dispense any e-cigarette products on prescription. The federal government's initial policy analysis assumed that once illegal products are harder to obtain, about 450,000 people will seek medical e-cigarette products.
However, many pharmacists have stated that they are unwilling to sell e-cigarettes due to moral reasons or because the process is too cumbersome. Illegal e-cigarettes are still widely available, but prices have soared to 40 to 60 Australian dollars per device as retailers increase prices to compensate for higher penalties.
Last week, officials at a Senate estimates hearing stated that they currently do not track how many pharmacies are selling e-cigarettes. Chief Medical Officer Tony Lawler said that obtaining a definitive answer is actually quite difficult.
Health Department official Chris Bedford provided data on the sale of e-cigarette products by pharmacies following patient consultations. He stated that the total number of these sales across Australia reached 3,500, and pharmacists are able to dispense multiple e-cigarette products based on notification, leading to patients coming in and engaging in conversations.
Anne Ruston, the Health spokesperson for the opposition party, stated that the number of e-cigarettes sold by pharmacies last month only accounted for a small fraction of estimated e-cigarette users in Australia.
"We know that most pharmacists do not want to become tobacco merchants, as clearly reflected in the department's statistics."
Due to e-cigarette products not being included in Australia's registered therapeutic goods list, pharmacists must prescribe and sell unapproved products. This has made pharmacists cautious about supplying e-cigarettes. Data from the pharmacy industry shows that the majority of people are not willing to stock e-cigarettes, with a survey finding that 86% of pharmacies do not stock them.
Richard Lee, CEO of pharmaceutical company Liber Pharmaceuticals, stated that despite a slow start, the pharmacy's e-cigarette program is progressing within a reasonable range. The slow progress is partially due to the timing of the introduction of new regulations and the implementation phase. Lee expects pharmacies to gradually adapt to the new regulations and achieve significant growth within the next three to six months.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.